PTC Inc. PTC
196.14 USD -0.41 (-0.21%)
At closeNov 11, 2026, 5:25 PM EST
196.14 0.00 0.00%
After hours · Nov 11, 5:25 PM ET
195.33 Day range 196.50
108.50 52-week range 196.79
- YTD
- +12.59%
- 1 year
- +10.19%
News
globenewswire.com BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: ADT Inc. (NYSE – ADT), RXO Inc. (NYSE – RXO), PTC Inc. (Nasdaq – PTC), Lifecore Biomedical, Inc. (Nasdaq – LFCR) BALA CYNWYD, Pa., Nov. 11, 2026 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky…
globenewswire.com Eos SENOLYTIX's PTC-2105 Reduced Semaglutide-Associated Lean-Mass Loss in Aged Mice: Data to Be Presented at 19th Sarcopenia, Cachexia & Wasting Disorders International Conference Data to highlight PTC-2105's attenuation of terminal lean-mass decline and semaglutide-associated lean-mass loss in aged mice PTC-2105 is Eos's lead clinical candidate in development for elderly…
businesswire.com PTC Stock Alert: Halper Sadeh LLC is Investigating Whether PTC Inc. is Obtaining a Fair Price for its Shareholders NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating the sale of PTC Inc. (NASDAQ: PTC) to Schneider Electric for $205.00 per share in cash.Halper Sadeh…
zacks.com PTC Inc. (PTC) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates While the top- and bottom-line numbers for PTC Inc. (PTC) give a sense of how the business performed in the quarter ended September 2026, it could be worth looking at how some of its key metrics…
zacks.com PTC Q4 Earnings & Revenues Beat Estimates, ARR Growth Strong PTC's Q4 fiscal 2026 earnings and revenues beat estimates, while ARR growth remain strong despite revenue declines and divestiture-related pressures.
zacks.com PTC Inc. (PTC) Surpasses Q4 Earnings and Revenue Estimates PTC Inc. (PTC) came out with quarterly earnings of $2.03 per share, beating the Zacks Consensus Estimate of $2 per share. This compares to earnings of $3.47 per share a year ago.
benzinga.com PTC Q4 Adj. EPS $2.03 Beats $1.96 Estimate, Sales $673.254M Beat $661.713M Estimate PTC (NASDAQ:PTC) reported quarterly earnings of $2.03 per share which beat the analyst consensus estimate of $1.96 by 3.57 percent. This is a 40.47 percent decrease over earnings of $3.41 per share…
prnewswire.com PTC ANNOUNCES FOURTH FISCAL QUARTER AND FULL FISCAL YEAR 2026 RESULTS Strategic focus on Intelligent Product Lifecycle vision BOSTON, Nov. 4, 2026 /PRNewswire/ -- PTC (NASDAQ: PTC) today reported financial results for its fourth fiscal quarter and full fiscal year…
benzinga.com Top 3 Tech Stocks That May Crash This Month Motorola Solutions, PTC and Manhattan Associates show overbought RSI readings above 70, warning momentum-focused investors of potential pullbacks.
globenewswire.com INVESTIGATION ALERT - The M&A Class Action Firm Is Investigating the Merger – OPCH, PTC, RXO and SYNA - IS IT A FAIR DEAL FOR YOU? NEW YORK, Nov. 04, 2026 (GLOBE NEWSWIRE) -- Class Action Attorney Juan Monteverde with Monteverde & Associates PC (the “M&A Class Action Firm”), has recovered millions of dollars for shareholders and…
prnewswire.com Are OPCH, PTC, RXO Obtaining Fair Deals for their Shareholders? /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws
prnewswire.com INVESTIGATION ALERT - The M&A Class Action Firm Is Investigating the Merger - OPCH, PTC, RXO and SYNA - IS IT A FAIR DEAL FOR YOU? /PRNewswire/ -- Class Action Attorney Juan Monteverde with Monteverde and Associates PC (the "M&A Class Action Firm"), has recovered millions of dollars for
seekingalpha.com PTC Therapeutics: Sephience Keeps Beating The Forecast, But The Price Already Knows PTC Therapeutics (PTCT) is rated Hold, bordering on Sell, with fair value estimated at $52/share versus a $59.97 current price. Sephience's strong launch drives growth, but legacy product declines…
prnewswire.com PTC Therapeutics Board of Directors Authorizes $500 Million Share Repurchase Program WARREN, N.J., Nov. 3, 2026 /PRNewswire/ -- PTC Therapeutics, Inc., (NASDAQ: PTCT) today announced that its Board of Directors has authorized a share repurchase program under which PTC may repurchase…
zacks.com PTC Heads Into Q4 Earnings as Schneider Buyout Looms: What's in Store? PTC's fiscal Q4 results hinge on ARR growth, AI adoption and cash flow momentum, while its pending $22.6 billion acquisition by Schneider Electric adds a key dimension.
prnewswire.com PTC Therapeutics to Participate in Upcoming Investor Conferences WARREN, N.J., Nov. 2, 2026 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that its executives will speak at the following conferences: Jefferies Global Healthcare Conference…
prnewswire.com PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) WARREN, N.J., Oct. 30, 2026 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that on Oct. 28, 2026, the company approved non-statutory stock options to purchase an aggregate of…
globenewswire.com BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: ADT Inc. (NYSE – ADT), RXO Inc. (NYSE – RXO), PTC Inc. (Nasdaq – PTC), Lifecore Biomedical, Inc. (Nasdaq – LFCR) BALA CYNWYD, Pa., Oct. 30, 2026 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky…
globenewswire.com Eos SENOLYTIX Reports Interim Data Showing Preserved Physical Function with MitoXcel Geropeptide PTC-2105 in a Second Species, Aged-Rat Study Interim Results in Super-Aged Rats Tested Externally Show Preserved Motor Performance and Reduced Fat Mass, Consistent with Prior Findings in Aged Mice Tested at Eos's R&D Facility; Data Support…
marketbeat.com PTC Therapeutics Q3 Earnings Call Highlights PTC Therapeutics NASDAQ: PTCT reported third-quarter 2026 total revenue of $358 million, including $276 million in net product revenue, as sales of phenylketonuria treatment Sephience continued to…
prnewswire.com PTC Therapeutics Provides Corporate Update and Reports Third Quarter 2026 Financial Results – Strong Q3 2026 performance with total revenue of $358 million, including $276 million of product revenue – – Full-year 2026 expected total revenue increased to $1.29 to $1.32 billion, with…
seekingalpha.com Parnassus Mid Cap Growth Fund: Q3 2026 Performance Review The portfolio's outperformance was primarily driven by our holdings in the Health Care sector, which delivered strong returns for the quarter on company-specific catalysts. Information Technology…
benzinga.com Top 3 Tech Stocks That May Keep You Up At Night This Month Accenture, Atlassian and PTC show overbought momentum signals, with RSI readings of 76.1, 72.1 and 79 after strong recent gains.
benzinga.com Treasury Yields Reach 24-Year Highs, Telecom Stocks Sell Off: This Week On Wall Street S&P 500 tops 7,800 as Treasury yields hit 24-year highs. AT&T, Verizon and T-Mobile sank thanks to SpaceX. Bank earnings and CPI are next.
benzinga.com Citigroup Maintains Neutral on PTC, Raises Price Target to $205 Citigroup analyst Tyler Radke maintains PTC (NASDAQ:PTC) with a Neutral and raises the price target from $141 to $205.
benzinga.com JP Morgan Upgrades PTC to Neutral, Raises Price Target to $205 JP Morgan analyst Alexei Gogolev upgrades PTC (NASDAQ:PTC) from Underweight to Neutral and raises the price target from $145 to $205.
benzinga.com This Gentex Analyst Turns Bearish; Here Are Top 5 Downgrades For Tuesday Analysts downgraded Gentex, Personalis, Goosehead Insurance, cutting ratings and several price targets.- benzinga.com Mizuho Maintains Neutral on PTC, Raises Price Target to $205 Mizuho analyst Siti Panigrahi maintains PTC (NASDAQ:PTC) with a Neutral and raises the price target from $160 to $205.
benzinga.com General Motors To Rally Around 40%? Here Are 10 Top Analyst Forecasts For Tuesday Wall Street analysts raised targets for PTC, Cloudflare, PENN, Microsoft and others, while downgrading PTC and upgrading PENN and Abbott.
benzinga.com BMO Capital Downgrades PTC to Market Perform, Raises Price Target to $205 BMO Capital analyst Daniel Jester downgrades PTC (NASDAQ:PTC) from Outperform to Market Perform and raises the price target from $164 to $205.
benzinga.com Nasdaq Surges Over 1% as Market Sentiment Improves — CNN Fear & Greed Index Climbs to 43, But ‘Fear’ Still Dominates U.S. stocks rose Monday, led by Nasdaq’s 1.05% gain, while CNN’s Fear & Greed Index improved to 43 but stayed in fear; PTC surged on $22.6B buyout.
benzinga.com Novavax, Nvidia, MercadoLibre, Nu Holdings and PTC: Why These 5 Stocks Are on Investors' Radars Today NVAX, NVDA, MELI, NU, PTC were among the stocks seen trending on Monday, Oct. 5, 2026.
benzinga.com QUICK SPARK: Brazil's Retail Broker XP Notches Best Day Ever, Tops Russell 1000 Performers XP Inc. jumped 34% to its best day ever, leading the Russell 1000 after Flávio Bolsonaro won the first round of Brazil's presidential vote.
benzinga.com 12 Information Technology Stocks Moving In Monday's Intraday Session Gainers Veea (NASDAQ:VEEA) shares increased by 49.8% to $4.99 during Monday's regular session. The market value of their outstanding shares is at $10.3 million. Socket Mobile (NASDAQ:SCKT) stock rose…- benzinga.com RBC Capital Downgrades PTC to Sector Perform, Raises Price Target to $306 RBC Capital analyst Matthew Hedberg downgrades PTC (NASDAQ:PTC) from Outperform to Sector Perform and raises the price target from $195 to $306.
benzinga.com Nasdaq 100 Hits Record, Brazil's EWZ Soars 13%: Stock Market Today Nasdaq 100 hits a record as Brazil's EWZ jumps 13% on Bolsonaro's election upset; ISM services prices hit a four-year high and the 10-year yield tops 5.3%.
benzinga.com RXO, Vaxcyte, PTC And Other Big Stocks Moving Higher On Monday U.S. stocks mixed as Dow falls 250+ points; RXO surges 23% on $5.8B C.H. Robinson deal, while Vaxcyte and PTC post major gains.
benzinga.com US Stocks Mixed; Nasdaq Gains Over 50 Points U.S. stocks mixed: Nasdaq and S&P 500 rose while Dow dipped. Weak jobs data pressured outlook; oil fell, while gold, silver and copper gained.
benzinga.com Industrial AI Arms Race Heats up: Schneider Electric Buys PTC for $22.6 Billion PTC stock jumps as Schneider Electric buys the industrial software firm for $22.6 billion ($205/share). Key deal terms & analysis here.
benzinga.com Why PTC Shares Are Trading Higher By Around 35%; Here Are 20 Stocks Moving Premarket PTC jumped 34.7% after Schneider Electric offered $22.6B; Columbus Acquisition soared 657.5%, while Zeta Network Group fell 23.3% premarket.
benzinga.com Schneider Electric To Acquire PTC For $205 Per Share In All-Cash Deal Valuing Equity At $22.6B, Funded By Equity And Debt Issuance Key HighlightsAll-cash acquisition at $205 per share for 100% of the share capital of PTC, valuing PTC’s equity at approximately $22.6 billion (€20.1 billion)Implied Enterprise Value of $23.7 billion…- benzinga.com Citigroup Maintains Neutral on PTC, Raises Price Target to $141 Citigroup analyst Tyler Radke maintains PTC (NASDAQ:PTC) with a Neutral and raises the price target from $127 to $141.
benzinga.com Barclays Maintains Overweight on PTC, Raises Price Target to $155 Barclays analyst Saket Kalia maintains PTC (NASDAQ:PTC) with a Overweight and raises the price target from $150 to $155.- benzinga.com Piper Sandler Maintains Neutral on PTC, Lowers Price Target to $157 Piper Sandler analyst Clarke Jeffries maintains PTC (NASDAQ:PTC) with a Neutral and lowers the price target from $175 to $157.
- benzinga.com PTC Sees Q4 Adj EPS $1.63-$2.21 vs $1.81 Est; Sees Sales $630.000M-$690.000M vs $649.518M Est PTC (NASDAQ:PTC) is looking for Q4 Adj EPS of $1.63-$2.21 vs $1.81 analyst estimate. sees sales of $630.000 million-$690.000 million vs $649.518 million analyst estimate.
- benzinga.com PTC Narrows FY2026 Adj EPS Guidance from $6.65-$8.90 to $7.87-$8.42 vs $7.83 Est; Raises FY2026 Sales Guidance from $2.580B-$2.820B to $2.690B-$3.750B vs $2.725B Est PTC (NASDAQ:PTC) narrows FY2026 Adj EPS guidance from $6.65-$8.90 to $7.87-$8.42 vs $7.83 analyst estimate. Raises FY2026 sales outlook from $2.580 billion-$2.820 billion to $2.690 billion-$3.750…
- benzinga.com PTC Q3 Adj. EPS $1.58 Beats $1.57 Estimate, Sales $600.049M Miss $608.056M Estimate PTC (NASDAQ:PTC) reported quarterly earnings of $1.58 per share which beat the analyst consensus estimate of $1.57 by 0.64 percent. This is a 3.66 percent decrease over earnings of $1.64 per share…
benzinga.com Barclays Maintains Overweight on PTC, Lowers Price Target to $150 Barclays analyst Saket Kalia maintains PTC (NASDAQ:PTC) with a Overweight and lowers the price target from $185 to $150.
benzinga.com BNP Paribas Initiates Coverage On PTC with Neutral Rating, Announces Price Target of $130 BNP Paribas analyst Andrew DeGasperi initiates coverage on PTC (NASDAQ:PTC) with a Neutral rating and announces Price Target of $130.
benzinga.com Chips Lead Nasdaq 100 Rebound, Oracle Sinks 11%: Stock Market Today The S&P 500 gained 0.5% while the tech-heavy Nasdaq 100 rose 1.1% by midday Thursday, extending a rebound from one-month lows.